Dighe, H.; Sarkale, P.; Patil, D.Y.; Mohandas, S.; Shete, A.M.; Sahay, R.R.; Lakra, R.; Patil, S.; Majumdar, T.; Gawande, P.;
et al. Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern. Vaccines 2022, 10, 1962.
https://doi.org/10.3390/vaccines10111962
AMA Style
Dighe H, Sarkale P, Patil DY, Mohandas S, Shete AM, Sahay RR, Lakra R, Patil S, Majumdar T, Gawande P,
et al. Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern. Vaccines. 2022; 10(11):1962.
https://doi.org/10.3390/vaccines10111962
Chicago/Turabian Style
Dighe, Hitesh, Prasad Sarkale, Deepak Y. Patil, Sreelekshmy Mohandas, Anita M. Shete, Rima R. Sahay, Rajen Lakra, Savita Patil, Triparna Majumdar, Pranita Gawande,
and et al. 2022. "Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern" Vaccines 10, no. 11: 1962.
https://doi.org/10.3390/vaccines10111962
APA Style
Dighe, H., Sarkale, P., Patil, D. Y., Mohandas, S., Shete, A. M., Sahay, R. R., Lakra, R., Patil, S., Majumdar, T., Gawande, P., Yemul, J., Vedpathak, P., & Yadav, P. D.
(2022). Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern. Vaccines, 10(11), 1962.
https://doi.org/10.3390/vaccines10111962